{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:49:07Z","timestamp":1787161747798,"version":"build-2736575974"},"reference-count":120,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Chronic liver disease (CLD) is a high morbidity and mortality condition with a high incidence\/prevalence worldwide. Despite the diverse etiological factors involved, common pathogenic hallmarks in CLD progression are the accumulation of scarring hepatic tissue and a sustained local and systemic inflammatory response. Considering the constant exposure of the liver to antigens and the delicate homeostatic immune surveillance that takes place in the organ, hepatic antigen presenting cells (hAPCs; i.e. Kupffer Cells, Liver Sinusoidal Endothelial Cells and Dendritic Cells) and their activity regulation are key players in the maintenance of intrahepatic immune tolerance. Epigenetic regulation is considered as a relevant mechanism in several stages of CLD development, currently recognized for playing a pivotal role in hepatic stellate cells activation in liver fibrosis as well as tumor suppressor gene silencing and tumoral microenvironment immune-escape. However, influence of epigenetic mechanisms over immune response in CLD continues under study. Here we comprehensively review the main epigenetic regulatory mechanisms controlling hAPCs regulation, considering the intricate crosstalk of epigenetic effectors and discussing recent studies supporting epigenetic interventions with promising therapeutical potential over inflammatory response during CLD progression.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1783588","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T04:13:49Z","timestamp":1776658429000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Epigenetic reprogramming of hepatic antigen presenting cells in chronic liver disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Enrique","family":"\u00c1ngel-Gomis","sequence":"first","affiliation":[{"name":"Hepatic and Intestinal Immunobiology Group, Dpto. Medicina Cl\u00ednica and Instituto Instituto de Investigaci\u00f3n, Desarrollo e Innovaci\u00f3n en Biotecnolog\u00eda sanitaria de Elche (IDIBE), Universidad Miguel Hern\u00e1ndez","place":["San Juan de Alicante, Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria y Biom\u00e9dica de Alicante (IIS ISABIAL), Hospital General Universitario Dr. Balmis","place":["Alicante, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Juanola","sequence":"additional","affiliation":[{"name":"Hepatic and Intestinal Immunobiology Group, Dpto. Medicina Cl\u00ednica and Instituto Instituto de Investigaci\u00f3n, Desarrollo e Innovaci\u00f3n en Biotecnolog\u00eda sanitaria de Elche (IDIBE), Universidad Miguel Hern\u00e1ndez","place":["San Juan de Alicante, Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria y Biom\u00e9dica de Alicante (IIS ISABIAL), Hospital General Universitario Dr. Balmis","place":["Alicante, Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red. Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd), Instituto de Salud Carlos III","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Caparr\u00f3s","sequence":"additional","affiliation":[{"name":"Hepatic and Intestinal Immunobiology Group, Dpto. Medicina Cl\u00ednica and Instituto Instituto de Investigaci\u00f3n, Desarrollo e Innovaci\u00f3n en Biotecnolog\u00eda sanitaria de Elche (IDIBE), Universidad Miguel Hern\u00e1ndez","place":["San Juan de Alicante, Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria y Biom\u00e9dica de Alicante (IIS ISABIAL), Hospital General Universitario Dr. Balmis","place":["Alicante, Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red. Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd), Instituto de Salud Carlos III","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rub\u00e9n","family":"Franc\u00e9s","sequence":"additional","affiliation":[{"name":"Hepatic and Intestinal Immunobiology Group, Dpto. Medicina Cl\u00ednica and Instituto Instituto de Investigaci\u00f3n, Desarrollo e Innovaci\u00f3n en Biotecnolog\u00eda sanitaria de Elche (IDIBE), Universidad Miguel Hern\u00e1ndez","place":["San Juan de Alicante, Spain"]},{"name":"Instituto de Investigaci\u00f3n Sanitaria y Biom\u00e9dica de Alicante (IIS ISABIAL), Hospital General Universitario Dr. Balmis","place":["Alicante, Spain"]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red. Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd), Instituto de Salud Carlos III","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2016.3","article-title":"Liver immunology and its role in inflammation and homeostasis","volume":"13","author":"Robinson","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1042\/cs20190654","article-title":"The immune niche of the liver","volume":"135","author":"Cheng","year":"2021","journal-title":"Clin Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nri2858","article-title":"Antigen-presenting cell function in the tolerogenic liver environment","volume":"10","author":"Thomson","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(10)60147-x","article-title":"Liver cirrhosis","volume":"398","author":"Gines","year":"2021","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2015.1021905","article-title":"Presentation and complications associated with cirrhosis of the liver","volume":"31","author":"Poordad","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"B7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.14309\/01.ajg.0001136872.01670.4b","article-title":"Liver fibrosis","volume":"29","author":"Aydin","year":"2018","journal-title":"Turk J Gastroenterol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2022.152315","article-title":"Monocyte-derived immature dendritic cells negatively regulate hepatic stellate cells in vitro by secreting IL-10","volume":"228","author":"Xu","year":"2023","journal-title":"Immunobiology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-00411-3","article-title":"Role of liver sinusoidal endothelial cells in liver diseases","volume":"18","author":"Gracia-Sancho","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00293","article-title":"Causes and consequences of innate immune dysfunction in cirrhosis","volume":"10","author":"Irvine","year":"2019","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.10.044","article-title":"Multi-modal analysis of human hepatic stellate cells identifies novel therapeutic targets for metabolic dysfunction-associated steatotic liver disease","volume":"82","author":"Kim","year":"2025","journal-title":"J Hepatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20102507","article-title":"Epigenetic mechanisms in hepatic stellate cell activation during liver fibrosis and carcinogenesis","volume":"20","author":"Barcena-Varela","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/s0168-8278(23)01307-7","article-title":"Identification and experimental validation of druggable epigenetic targets in hepatoblastoma","volume":"79","author":"Claveria-Cabello","year":"2023","journal-title":"J Hepatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.025","article-title":"Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications","volume":"73","author":"Carrillo-Reixach","year":"2020","journal-title":"J Hepatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adg3358","article-title":"Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology","volume":"15","author":"Ji","year":"2023","journal-title":"Sci Transl Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejphar.2018.08.021","article-title":"Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy","volume":"837","author":"Biswas","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1685","article-title":"Epigenetic modifications and human disease","volume":"28","author":"Portela","year":"2010","journal-title":"Nat Biotechnol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer epigenetics: from mechanism to therapy","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2017.10.011","article-title":"Epigenetic reprogramming in liver fibrosis and cancer","volume":"121","author":"Wilson","year":"2017","journal-title":"Adv Drug Delivery Rev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002750","article-title":"In vivo control of CpG and non-CpG DNA methylation by DNA methyltransferases","volume":"8","author":"Arand","year":"2012","journal-title":"PloS Genet"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201488290","article-title":"Playing TETris with DNA modifications","volume":"33","author":"Delatte","year":"2014","journal-title":"EMBO J"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.08.011","article-title":"The language of histone crosstalk","volume":"142","author":"Lee","year":"2010","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2017.04.007","article-title":"Epigenetics and liver fibrosis","volume":"4","author":"Moran-Salvador","year":"2017","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/cells9102321","article-title":"Epigenetics in liver fibrosis: Could HDACs be a therapeutic target","volume":"9","author":"Claveria-Cabello","year":"2020","journal-title":"Cells"},{"key":"B27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cell.2014.03.008","article-title":"The noncoding RNA revolution-trashing old rules to forge new ones","volume":"157","author":"Cech","year":"2014","journal-title":"Cell"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-311292","article-title":"Epigenetics in liver disease: from biology to therapeutics","volume":"65","author":"Hardy","year":"2016","journal-title":"Gut"},{"key":"B29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41418-023-01213-1","article-title":"Mapping epigenetic modifications by sequencing technologies","volume":"32","author":"Chen","year":"2025","journal-title":"Cell Death Differ"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.11.024","article-title":"Hepatic stellate cell transdifferentiation involves genome-wide remodeling of the DNA methylation landscape","volume":"64","author":"Page","year":"2016","journal-title":"J Hepatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jcmgh.2018.09.005","article-title":"Enhancer of Zeste Homologue 2 inhibition attenuates TGF-beta dependent hepatic stellate cell activation and liver fibrosis","volume":"7","author":"Martin-Mateos","year":"2019","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155657","article-title":"SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis","volume":"146","author":"Shen","year":"2023","journal-title":"Metabolism"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-018-0383-0","article-title":"PSTPIP2 connects DNA methylation to macrophage polarization in CCL4-induced mouse model of hepatic fibrosis","volume":"37","author":"Yang","year":"2018","journal-title":"Oncogene"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118804","article-title":"Antagonizing epigenetically controlled PAF\/PAF-R pathway improves liver function during experimental cirrhosis","volume":"193","author":"Angel-Gomis","year":"2025","journal-title":"BioMed Pharmacother"},{"key":"B35","doi-asserted-by":"publisher","first-page":"8523","DOI":"10.1038\/ncomms9523","article-title":"miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program","volume":"6","author":"Su","year":"2015","journal-title":"Nat Commun"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2013.12.023","article-title":"SOCS1 hypermethylation mediated by DNMT1 is associated with lipopolysaccharide-induced inflammatory cytokines in macrophages","volume":"225","author":"Cheng","year":"2014","journal-title":"Toxicol Lett"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.10.002","article-title":"MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis","volume":"138","author":"Mann","year":"2010","journal-title":"Gastroenterology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2016.10.004","article-title":"A proof-of-concept for epigenetic therapy of tissue fibrosis: Inhibition of liver fibrosis progression by 3-Deazaneplanocin A","volume":"25","author":"Zeybel","year":"2017","journal-title":"Mol Ther"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13153","article-title":"EZH2-mediated repression of Dkk1 promotes hepatic stellate cell activation and hepatic fibrosis","volume":"21","author":"Yang","year":"2017","journal-title":"J Cell Mol Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118677","article-title":"Interleukin-22 regulating Kupffer cell polarization through STAT3\/Erk\/Akt crosstalk pathways to extenuate liver fibrosis","volume":"264","author":"Su","year":"2021","journal-title":"Life Sci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41419-018-0670-2","article-title":"Enhancer of zeste homolog 2-catalysed H3K27 trimethylation plays a key role in acute-on-chronic liver failure via TNF-mediated pathway","volume":"9","author":"Zhou","year":"2018","journal-title":"Cell Death Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22231","article-title":"S-adenosylmethionine inhibits lipopolysaccharide-induced gene expression via modulation of histone methylation","volume":"47","author":"Ara","year":"2008","journal-title":"Hepatology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.104996","article-title":"Cross talk between the liver microbiome and epigenome in patients with metabolic dysfunction-associated steatotic liver disease","volume":"101","author":"Pirola","year":"2024","journal-title":"EBioMedicine"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2011.05.029","article-title":"Activation of inactive hepatocytes through histone acetylation: a mechanism for functional compensation after massive loss of hepatocytes","volume":"179","author":"Shi","year":"2011","journal-title":"Am J Pathol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.7150\/thno.30707","article-title":"p300\/CBP inhibitor A-485 alleviates acute liver injury by regulating macrophage activation and polarization","volume":"9","author":"Peng","year":"2019","journal-title":"Theranostics"},{"key":"B46","doi-asserted-by":"publisher","first-page":"100235","DOI":"10.1074\/jbc.ra120.016079","article-title":"Dysregulation of intercellular signaling by MOF deletion leads to liver injury","volume":"296","author":"Lei","year":"2021","journal-title":"J Biol Chem"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31617","article-title":"Endothelial p300 promotes portal hypertension and hepatic fibrosis through C-C motif chemokine ligand 2-mediated angiocrine signaling","volume":"73","author":"Gao","year":"2021","journal-title":"Hepatology"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/toxics11110928","article-title":"Suppressed histone H3 lysine 18 acetylation is involved in arsenic-induced liver fibrosis in rats by triggering the dedifferentiation of liver sinusoidal endothelial cells","volume":"11","author":"Hu","year":"2023","journal-title":"Toxics"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12991","article-title":"Sirtuin 1 ameliorates defenestration in hepatic sinusoidal endothelial cells during liver fibrosis via inhibiting stress-induced premature senescence","volume":"54","author":"Luo","year":"2021","journal-title":"Cell Prolif"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/s0016-5085(19)39932-9","article-title":"Mechanotransduction-induced glycolysis epigenetically regulates a CXCL1-dominant angiocrine signaling program in liver sinusoidal endothelial cells in vitro and in vivo","volume":"77","author":"Greuter","year":"2022","journal-title":"J Hepatol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.174775","article-title":"Liver sinusoidal endothelial cells contribute to portal hypertension through collagen type IV-driven sinusoidal remodeling","volume":"9","author":"Gan","year":"2024","journal-title":"JCI Insight"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2019.10.109","article-title":"BRG1 deficiency in endothelial cells alleviates thioacetamide induced liver fibrosis in mice","volume":"521","author":"Shao","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2022.101664","article-title":"Protocol to isolate and analyze mouse bone marrow derived dendritic cells (BMDC)","volume":"3","author":"Sauter","year":"2022","journal-title":"STAR Protoc"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24621","article-title":"Dendritic cell regulation of carbon tetrachloride-induced murine liver fibrosis regression","volume":"55","author":"Jiao","year":"2012","journal-title":"Hepatology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.molimm.2016.09.010","article-title":"BET bromodomain inhibition reduces maturation and enhances tolerogenic properties of human and mouse dendritic cells","volume":"79","author":"Schilderink","year":"2016","journal-title":"Mol Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41419-020-03219-w","article-title":"Inhibition of EZH2 ameliorates bacteria-induced liver injury by repressing RUNX1 in dendritic cells","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1038\/s41467-019-09903-6","article-title":"Mettl3-mediated mRNA m(6)A methylation promotes dendritic cell activation","volume":"10","author":"Wang","year":"2019","journal-title":"Nat Commun"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-0916-x","article-title":"Anti-tumour immunity controlled through mRNA m(6)A methylation and YTHDF1 in dendritic cells","volume":"566","author":"Han","year":"2019","journal-title":"Nature"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.01.021","article-title":"CCR7 chemokine receptor-inducible lnc-Dpf3 restrains dendritic cell migration by inhibiting HIF-1alpha-mediated glycolysis","volume":"50","author":"Liu","year":"2019","journal-title":"Immunity"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2025.101980","article-title":"Epigenetic mechanisms in HCC immune landscape: Therapeutic implications","volume":"79","author":"Fernandez-Barrena","year":"2025","journal-title":"Semin Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.04.018","article-title":"Differentiation therapy by epigenetic reconditioning exerts antitumor effects on liver cancer cells","volume":"26","author":"Gailhouste","year":"2018","journal-title":"Mol Ther"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-018-0658-x","article-title":"Phase I\/II study of first-line combination therapy with sorafenib plus resminostat, an oral HDAC inhibitor, versus sorafenib monotherapy for advanced hepatocellular carcinoma in east Asian patients","volume":"36","author":"Tak","year":"2018","journal-title":"Invest New Drugs"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1802691115","article-title":"Inhibition of enhancer of zeste homolog 2 (EZH2) induces natural killer cell-mediated eradication of hepatocellular carcinoma cells","volume":"115","author":"Bugide","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"B64","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13046-016-0311-5","article-title":"Depletion of histone demethylase KDM5B inhibits cell proliferation of hepatocellular carcinoma by regulation of cell cycle checkpoint proteins p15 and p27","volume":"35","author":"Wang","year":"2016","journal-title":"J Exp Clin Cancer Res"},{"key":"B65","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s13105-025-01095-6","article-title":"Expression landscape of epigenetic genes in human hepatocellular carcinoma","volume":"81","author":"Castello-Uribe","year":"2025","journal-title":"J Physiol Biochem"},{"key":"B66","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13046-018-0832-1","article-title":"Osteopontin alters DNA methylation through up-regulating DNMT1 and sensitizes CD133+\/CD44+ cancer stem cells to 5 azacytidine in hepatocellular carcinoma","volume":"37","author":"Gao","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"B67","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40880-019-0401-9","article-title":"Associations of PGK1 promoter hypomethylation and PGK1-mediated PDHK1 phosphorylation with cancer stage and prognosis: a TCGA pan-cancer analysis","volume":"39","author":"Shao","year":"2019","journal-title":"Cancer Commun (Lond)"},{"key":"B68","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41419-018-0485-1","article-title":"Exosomal circRNA_100284 from arsenite-transformed cells, via microRNA-217 regulation of EZH2, is involved in the Malignant transformation of human hepatic cells by accelerating the cell cycle and promoting cell proliferation","volume":"9","author":"Dai","year":"2018","journal-title":"Cell Death Dis"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2019.05.049","article-title":"Epigenetic inactivation of LHX6 mediated microcystin-LR induced hepatocarcinogenesis via the Wnt\/beta-catenin and P53 signaling pathways","volume":"252","author":"Chen","year":"2019","journal-title":"Environ pollut"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.9390","article-title":"DNMTs inhibitor SGI-1027 induces apoptosis in Huh7 human hepatocellular carcinoma cells","volume":"16","author":"Sun","year":"2018","journal-title":"Oncol Lett"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28838","article-title":"Extracellular vesicles released by hepatocytes from gastric infusion model of alcoholic liver disease contain a MicroRNA barcode that can be detected in blood","volume":"65","author":"Eguchi","year":"2017","journal-title":"Hepatology"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1061","article-title":"LncRNA AK054921 and AK128652 are potential serum biomarkers and predictors of patient survival with alcoholic cirrhosis","volume":"1","author":"Yang","year":"2017","journal-title":"Hepatol Commun"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1111\/add.15020","article-title":"Acute alcohol withdrawal and recovery in men lead to profound changes in DNA methylation profiles: a longitudinal clinical study","volume":"115","author":"Witt","year":"2020","journal-title":"Addiction"},{"key":"B74","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13148-015-0056-6","article-title":"Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease","volume":"7","author":"Zeybel","year":"2015","journal-title":"Clin Epigenet"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2007.07.030","article-title":"Distinct methylation patterns in histone H3 at Lys-4 and Lys-9 correlate with up- & down-regulation of genes by ethanol in hepatocytes","volume":"81","author":"Pal-Bhadra","year":"2007","journal-title":"Life Sci"},{"key":"B76","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.alcohol.2017.01.009","article-title":"Binge alcohol alters PNPLA3 levels in liver through epigenetic mechanism involving histone H3 acetylation","volume":"60","author":"Restrepo","year":"2017","journal-title":"Alcohol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1007\/s13105-023-00976-y","article-title":"Comprehensive analysis of epigenetic and epitranscriptomic genes' expression in human NAFLD","volume":"79","author":"Herranz","year":"2023","journal-title":"J Physiol Biochem"},{"key":"B78","first-page":"89","article-title":"(Na+-K+)-ATPase activities in rat tissues during pregnancy","volume":"8","author":"Zamora","year":"1987","journal-title":"Biol Res Pregnancy Perinatol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.10.059","article-title":"Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21","volume":"146","author":"Li","year":"2014","journal-title":"Gastroenterology"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136908","article-title":"Circulating microRNA profiles in patients with type-1 autoimmune hepatitis","volume":"10","author":"Migita","year":"2015","journal-title":"PloS One"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v17.i8.108182","article-title":"Nutrients as epigenetic modulators in metabolic dysfunction-associated steatotic liver disease","volume":"17","author":"Rodriguez","year":"2025","journal-title":"World J Hepatol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines14010120","article-title":"MicroRNAs as key regulators in the progression of metabolic dysfunction-associated steatotic liver disease: a bioinformatics analysis","volume":"14","author":"Locatelli","year":"2026","journal-title":"Biomedicines"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1510322","article-title":"Targeting fibroblast growth factor (FGF)-21: a promising strategy for metabolic dysfunction-associated steatotic liver disease treatment","volume":"16","author":"Cui","year":"2025","journal-title":"Front Pharmacol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07087-8","article-title":"Durable and efficient gene silencing in vivo by hit-and-run epigenome editing","volume":"627","author":"Cappelluti","year":"2024","journal-title":"Nature"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03508-x","article-title":"A potent epigenetic editor targeting human PCSK9 for durable reduction of low-density lipoprotein cholesterol levels","volume":"31","author":"Tremblay","year":"2025","journal-title":"Nat Med"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt852","article-title":"Miravirsen (SPC3649) can inhibit the biogenesis of miR-122","volume":"42","author":"Gebert","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(16)31715-9","article-title":"Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial","volume":"389","author":"van der Ree","year":"2017","journal-title":"Lancet"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkag073","article-title":"Chromatin remodeler BAF maintains HBV cccDNA transcriptional competence and represents a therapeutic target","volume":"54","author":"Huang","year":"2026","journal-title":"Nucleic Acids Res"},{"key":"B89","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41392-024-02039-0","article-title":"Epigenetics-targeted drugs: current paradigms and future challenges","volume":"9","author":"Dai","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-018-0773-9","article-title":"Safety and tolerability of histone deacetylase (HDAC) inhibitors in oncology","volume":"42","author":"Shah","year":"2019","journal-title":"Drug Saf"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14054","article-title":"A phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunction","volume":"85","author":"Takebe","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2019.10.034","article-title":"PRMT5 inhibition induces pro-inflammatory macrophage polarization and increased hepatic triglyceride levels without affecting atherosclerosis in mice","volume":"27","author":"Zhang","year":"2023","journal-title":"J Cell Mol Med"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noac139","article-title":"Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: a multicenter, open-label, phase Ib\/II trial","volume":"25","author":"de la Fuente","year":"2023","journal-title":"Neuro Oncol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.104651","article-title":"Identification of nonhistone substrates of the lysine methyltransferase PRDM9","volume":"299","author":"Hanquier","year":"2023","journal-title":"J Biol Chem"},{"key":"B95","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/s41419-018-1014-y","article-title":"MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis","volume":"9","author":"Fernandez-Ramos","year":"2018","journal-title":"Cell Death Dis"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2024.171237","article-title":"Environmental arsenic pollution induced liver oxidative stress injury by regulating miR-155 through inhibition of AUF1","volume":"922","author":"Lv","year":"2024","journal-title":"Sci Total Environ"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.09.015","article-title":"miR-155 promotes T follicular helper cell accumulation during chronic, low-grade inflammation","volume":"41","author":"Hu","year":"2014","journal-title":"Immunity"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.01.035","article-title":"The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis","volume":"64","author":"Bala","year":"2016","journal-title":"J Hepatol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2023.07.012","article-title":"Therapeutic inhibition of miR-155 attenuates liver fibrosis via STAT3 signaling","volume":"33","author":"Bala","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.2.307","article-title":"Dendritic cells and immune regulation in the liver","volume":"52","author":"Lau","year":"2003","journal-title":"Gut"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0231132","article-title":"A protocol for rapid monocyte isolation and generation of singular human monocyte-derived dendritic cells","volume":"15","author":"Chometon","year":"2020","journal-title":"PloS One"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3390\/cimb45050269","article-title":"The epigenetic reader protein SP140 regulates dendritic cell activation, maturation and tolerogenic potential","volume":"45","author":"Ghiboub","year":"2023","journal-title":"Curr Issues Mol Biol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"13484","DOI":"10.1038\/s41598-022-16754-7","article-title":"Single-cell transcriptome and cell type-specific molecular pathways of human non-alcoholic steatohepatitis","volume":"12","author":"Fred","year":"2022","journal-title":"Sci Rep"},{"key":"B104","doi-asserted-by":"publisher","first-page":"19396","DOI":"10.1038\/s41598-021-98806-y","article-title":"Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis","volume":"11","author":"Wang","year":"2021","journal-title":"Sci Rep"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3390\/cells8050503","article-title":"Single cell RNA sequencing identifies subsets of hepatic stellate cells and myofibroblasts in liver fibrosis","volume":"8","author":"Krenkel","year":"2019","journal-title":"Cells"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2019.07.028","article-title":"Landscape of intercellular crosstalk in healthy and NASH liver revealed by single-cell secretome gene analysis","volume":"75","author":"Xiong","year":"2019","journal-title":"Mol Cell"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1624883","article-title":"Integration of single-cell sequencing, transcriptome sequencing, and machine learning for constructing and validating histone acetylation-related prognostic risk models in hepatocellular carcinoma","volume":"17","author":"Qi","year":"2026","journal-title":"Front Immunol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41467-024-55325-4","article-title":"Spatial transcriptomics of healthy and fibrotic human liver at single-cell resolution","volume":"16","author":"Watson","year":"2025","journal-title":"Nat Commun"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.2001","article-title":"Spatial transcriptomics identifies enriched gene expression and cell types in human liver fibrosis","volume":"6","author":"Chung","year":"2022","journal-title":"Hepatol Commun"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.06.004","article-title":"Single-cell genomics and spatial transcriptomics: Discovery of novel cell states and cellular interactions in liver physiology and disease biology","volume":"73","author":"Saviano","year":"2020","journal-title":"J Hepatol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/s44321-025-00230-6","article-title":"Spatial gene regulatory networks driving cell state transitions during human liver disease","volume":"17","author":"Hammond","year":"2025","journal-title":"EMBO Mol Med"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100524","article-title":"Understanding the cellular interactome of non-alcoholic fatty liver disease","volume":"4","author":"Wallace","year":"2022","journal-title":"JHEP Rep"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/s42003-025-08710-8","article-title":"Chromatin dynamics and regulatory drivers of hypoplastic hepatic progenitor cells in partial hepatectomy model","volume":"8","author":"Wu","year":"2025","journal-title":"Commun Biol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115633","article-title":"Transcriptional landscape and chromatin accessibility reveal key regulators for liver regenerative initiation and organoid formation","volume":"44","author":"Lian","year":"2025","journal-title":"Cell Rep"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2023.06.018","article-title":"Effect of distinct ECM microenvironments on the genome-wide chromatin accessibility and gene expression responses of hepatic stellate cells","volume":"167","author":"Jain","year":"2023","journal-title":"Acta Biomater"},{"key":"B116","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/s42003-025-08160-2","article-title":"Increased matrix stiffness promotes fibrogenesis of hepatic stellate cells through AP-1-induced chromatin priming","volume":"8","author":"Zhao","year":"2025","journal-title":"Commun Biol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1106-z","article-title":"KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3","volume":"18","author":"Lan","year":"2019","journal-title":"Mol Cancer"},{"key":"B118","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1038\/s41598-024-53993-2","article-title":"Technical optimization of spatially resolved single-cell transcriptomic datasets to study clinical liver disease","volume":"14","author":"Rocque","year":"2024","journal-title":"Sci Rep"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000001023","article-title":"Epigenetic heterogeneity hotspots in human liver disease progression","volume":"81","author":"Hlady","year":"2025","journal-title":"Hepatology"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-12-804274-8.00015-1","article-title":"Epigenetics in liver disease","volume":"60","author":"Mann","year":"2014","journal-title":"Hepatology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1783588\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T04:13:50Z","timestamp":1776658430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1783588\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":120,"alternative-id":["10.3389\/fimmu.2026.1783588"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1783588","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"article-number":"1783588"}}